Multimodal treatment of rectal cancer

Best Practice and Research: Clinical Gastroenterology

Volumn 21, Issue 6, 2007, Pages 1049-1070

  Glynne Jones, Rob ^a   Mathur, Pawan ^b   Elton, Colin ^b   Train, Matthew L ^c  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b BARNET HOSPITAL   (United Kingdom)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

chemoradiotherapy; chemotherapy; circumferential resection margin; local excision; magnetic resonance imaging; radiotherapy; rectal adenocarcinoma; staging; surgery, laparascopic surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; OXALIPLATIN;

ADJUVANT THERAPY; ADVANCED CANCER; ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; COLON CANCER; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; DIAGNOSTIC ACCURACY; DRUG DOSE REGIMEN; FATALITY; GASTROINTESTINAL TOXICITY; HUMAN; LAPAROSCOPIC SURGERY; LOW DRUG DOSE; LYMPH NODE METASTASIS; MICROMETASTASIS; MONOTHERAPY; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; QUALITY CONTROL; RECTUM CANCER; SEXUAL DYSFUNCTION; SURGICAL TECHNIQUE; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME; URINARY TRACT DISEASE; ABDOMINAL SURGERY; ADJUVANT CHEMOTHERAPY; DIAGNOSTIC IMAGING; METHODOLOGY; MICTURITION DISORDER; PATHOLOGY; PATIENT CARE; PATIENT SELECTION; RECTUM TUMOR; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DIAGNOSTIC IMAGING; DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; NEOPLASM STAGING; PATIENT CARE TEAM; PATIENT SELECTION; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TREATMENT OUTCOME; URINATION DISORDERS;

EID: 36849010200     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2007.11.003     Document Type: Article

References (106)

1. Quirke P., Durdey P., Dixon M.F., et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet ii (1986) 996-999
2. Beets-Tan R.G. MRI in rectal cancer: the T stage and circumferential resection margin. Colorectal Dis 5 (2003) 392-395
3. Brown G., Radcliffe A.G., Newcombe R.G., et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90 (2003) 355-364
4. Martling A., Holm T., Bremmer S., et al. Prognostic value of preoperative magnetic resonance imaging of the pelvis in rectal cancer. Br J Surg 90 (2003) 1422-1428
5. Daniels I. MRI predicts surgical resection margin status in patients with rectal cancer: results from the Mercury Study Group. Clin Oncol 16 (2004) S45-S46
6. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 333 (2006) 779
7. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 639-646
8. Sauer R., Becker H., Hohenberger W., et al. German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
9. Bosset J.F., Collette L., Calais G., et al. Chemotherapy with pre-operative radiotherapy in rectal cancer. N Engl J Med 355 (2006) 1114-1123
10. Gerard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-T4 rectal cancers: results of FFCD 9203. J Clin Oncol 24 (2006) 4620-4625
11. Hall N.R., Finan P.J., al-Jaberi T., et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence?. Dis Colon Rectum 41 (1998) 979-983
12. Wibe A., Rendedal P.R., Svensson E., et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89 (2002) 327-334
13. Branagan G., Chave H., Fuller C., et al. Can magnetic resonance imaging predict circumferential margins and stage in rectal cancer?. Dis Colon Rectum 47 (2004) 1317-1322
14. Nagtegaal I.D., van de Velde C.J., Marijnen C.A., et al., Dutch Colorectal Cancer Group. The Pathology Review Committee. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 23 (2005) 9257-9264
15. Nagtegaal I.D., Marijnen C.A., Kranenbarg E.K., et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal cancer: not 1 millimetre but 2 millimetres is the limit. Am J Surg Pathol 26 (2002) 350-357
16. Tepper J.E., O'Conell M.J., and Niedzwiecki D. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19 (2001) 157-163
17. Quirke P., and Dixon M.F. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorect Dis 3 (1988) 127-131
18. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomized trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72 (2004) 15-24
19. Hermanek P., Guggenmoos-Holzmann I., and Gall F.P. Prognostic factors in rectal carcinoma. A contribution to the further development of tumour classification. Dis Colon Rectum 32 (1989) 593-599
20. Heald R.J. The 'holy plane' of rectal surgery. J R Soc Med 81 (1988) 503-508
21. Brennan D.J., Moynagh M., Brannigan A.E., et al. Routine mobilisation of the splenic flexure is not necessary during anterior resection for rectal cancer. Dis Colon Rectum 50 (2007) 302-307
22. Low W.L., Choi H.K., Lee Y.M., et al. Anastomotic leakage is associated with poor long-term outcome in patients after curative resection for malignancy. J Gastrointest Surg 11 (2007) 8-15
23. Gastinger I., Marusch F., Steinert R., et al. Working Group 'Colon/Rectum Carcinoma'. Protective defunctioning stoma in low anterior resection for rectal carcinoma. Br J Surg 92 (2005) 1137-1142
24. Shirouzu K., Isimoto H., and Kakegawa T. Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery. Cancer 76 (1995) 388-392
25. Marr R., Birbeck K., Garvican J., et al. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg 242 (2005) 74-82
26. Platell C., Barwood N., Dorfmann G., et al. The incidence of anastomotic leaks in patients undergoing colorectal surgery. Colorect Dis 9 (2007) 71-79
27. Dehni N., McFadden N., McNamara D.A., et al. Oncologic results following abdominoperineal resection for adenocarcinoma of the low rectum. Dis Colon Rectum 46 (2003) 867-874
28. Salerno G., Sinnatamby C., Branagan G., et al. Defining the rectum: surgically, radiologically and anatomically. Colorect Dis 8 Suppl. 3 (2006) 5-9
29. Portier G., Ghouti L., Kirzin S., et al. Oncological outcome of ultra-low coloanal anastomosis with and without intersphincteric resection for low rectal adenocarcinoma. Br J Surg 94 (2007) 341-345
30. Koh P.K., Tang C.L., Eu K.W., et al. A systematic review of the function and complications of colonic pouches. Int J Colorect Dis 22 (2007) 543-548
31. Korkolis D.P., Plataniotis G.D., Gondikakis E., et al. Short-term pre-operative radiotherapy in locally advanced rectal cancer does not increase postoperative complications and improves the rate of sphincter-preserving surgery. J BUON 10 (2005) 365-370
32. Daniels I.R., Strassburg J., and Moran B.J. The need for future surgical low rectal cancer studies. Colorect Dis 8 Suppl. 3 (2006) 25-29
33. Holm T., Ljung A., Haggmark T., et al. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 94 (2007) 232-238
34. Bell S.W., Dehni N., Chaouat M., et al. Primary rectus abdominis myocutaneous flap for repair of perineal and vaginal defects after extended abdominoperineal resection. Br J Surg 92 (2005) 482-486
35. Gannon C.J., Zager J.S., Chang G.J., et al. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma. Ann Surg Oncol 14 (2007) 1870-1877
36. Moriya Y. Function preservation in rectal cancer surgery. Int J Clin Oncol 11 (2006) 339-343
37. Camilleri-Brennan J., and Steele R.J. The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol 27 (2001) 349
38. Birbeck K.F., Macklin C.P., Tiffin N.J., et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcome in rectal cancer surgery. Ann Surg 235 (2002) 449-457
39. Moriya Y., Sugihara K., Akasut A., et al. Importance of extended lymphadenonectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 21 (1997) 728-732
40. Papillon J. Rectal and Anal Cancers: Conservative Treatment by Radiation - an Alternative to Surgery (1982), Springer Verlag, New York
41. Papillon J. Surgical adjuvant therapy for rectal cancer: present options. Dis Colon Rectum 37 (1994) 144-148
42. Gerard J.P., Chappet O., Ramaioli A., et al. Long term control of T2-T3 rectal adenocarcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 54 (2002) 142-149
43. Sakamoto G.D., Mackeigan J.M., and Senagore A.J. Transanal excision of large, rectal villous adenomas. Dis Colon Rectum 34 (1991) 880-885
44. Featherstone J.M., Grabham J.A., and Fozard J.B. Peri-anal excision of large, rectal villous adenomas. Dis Colon Rectum 47 (2004) 86-89
45. Buess G., Theiss R., Gunther M., et al. Endoscopic surgery in the rectum. Endoscopy 17 (1985) 31-35
46. Buess G., Mentges B., Manncke K., et al. Technique and results of transanal endoscopic microsurgery in early rectal cancer. Am J Surg 163 (1992) 63-69
47. Bretagnol F., Merrie A., George B., et al. Local excision of rectal tumours by transanal endoscopic microsurgery. Br J Surg 94 (2007) 627-633
48. Maslekar S., Pillinger S.H., and Monson J.R. Transanal endoscopic microsurgery for carcinoma of the rectum. Surg Endosc 21 (2007) 97-102
49. Floyd N.D., and Saclarides T.J. Transanal endoscopic microsurgical resection of pT1 rectal tumours. Dis Colon Rectum 49 (2006) 164-168
50. Bach S., and Mortensen N. Analysis of national database for TEM resected rectal cancer. Colorect Dis 9 (2007) 187-188
51. Whitehouse P.A., Tilney H.S., Armitage J.N., et al. Transanal endoscopic microsurgery: risk factors for local recurrence of benign rectal adenomas. Colorect Dis 8 (2006) 795-799
52. Tuech J.J., Pessaux P., Regenet N., et al. Endoscopic transanal resection using the urological resectoscope in the management of patients with rectal villous adenomas. Int J Colorect Dis 19 (2004) 569-573
53. Hurlstone D.P., Sanders D.S., Cross S.S., et al. Colonoscopic resection of lateral spreading tumours: a prospective analysis of endoscopic mucosal resection. Gut 53 (2004) 1334-1339
54. Hurlstone D.P., Sanders D.S., Cross S.S., et al. A prospective analysis of extended endoscopic mucosal resection for large rectal villous adenomas: an alternative technique to transanal endoscopic microsurgery. Colorect Dis 7 (2005) 339-344
55. Steele Jr. G.D., Herndon J.E., Bleday R., et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol 6 (1999) 433-441
56. Kim C.J., Yeatman T.J., Coppula D., et al. Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg 234 (2001) 352-358
57. Lezoche E., Guerreri M., Paganini A.M., et al. Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery. Br J Surg 92 (2005) 1546-1552
58. Guillem J.G., Chessin D.B., Shia J., et al. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate endpoint. J Clin Oncol 23 (2005) 3475-3479
59. Tulchinsky H., Rabau M., Shacham-Shemueli E., et al. Can rectal cancers with pathological T0 after neoadjuvant chemoradiation (ypT0) be treated by transanal excision alone?. Ann Surg Oncol 13 (2005) 347-352
60. Habr-Gama A., de Souza P.M., Ribeiro U., et al. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 41 (1998) 1087-1096
61. Camma C., Giunta M., Fiorica F., et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 284 (2000) 1008-1015
62. Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 358 (2001) 1291-1304
63. Munro A.J., and Bentley A.H.M. Adjuvant radiotherapy in operable rectal cancer: a systematic review. Semin Colon Rect Surg 13 (2002) 31-42
64. Wong R., Tandan V., De Silva S., and Figueredo A. Preoperative radiotherapy and curative surgery for the management of localized rectal cancer. Cochrane Database Syst Rev 2 (2007) CD002102
65. Frykholm G.J., Glimelius B., and Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomised trial and evaluation of late secondary effects. Dis Colon Rectum 36 (1993) 564-572
66. Glimelius B., Isacson U., Jung B., et al. Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose response effect favouring preoperative treatment. Int J Radiat Oncol Biol Phys 37 (1997) 281-287
67. Roh M., Petrelli N., Wieand H., et al. Phase III randomised trial of preoperative versus postoperative mutimodality therapy in patients with carcinoma of the rectum (NSABP R-03). J Clin Oncol Proc ASCO 20 (2001) (Abstract 450)
68. Bujko K., Nowacki M.P., Nasierowska-Guttmejer, et al. Long-term results of a randomised trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93 (2006) 1215-1223
69. Bujko K., Kepka L., Michalski W., et al. Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol 80 (2006) 4-12
70. Anonymous. Improved survival with preoperative radiotherapy in resectable rectal cancer: Swedish Rectal Cancer Trial. N Engl J Med 336 (1997) 980-987
71. Sebag-Montefiore D., Steele R., Quirke P., et al. Routine short course preop radiotherapy or selective postoperative chemoradiotherapy for resectable rectal cancer? Preliminary results of MRC DR07 randomised trial. J Clin Oncol 24 (2006) 185 (Abstract 3511)
72. Sauer R., Fietkau R., Wittekind C., et al. Adjuvant versus neoadjuvant radio-chemotherapy for locally advanced rectal cancer. Strahlenther Onkol 177 (2001) 173-181
73. Wibe A., Syse A., Andersen E., et al. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs abdominoperineal resection. Dis Colon Rectum 47 (2004) 48-58
74. Tekkis P.P., Heriot A.G., and Smith J. Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer. Colorect Dis 7 (2005) 369-374
75. Marijnen C.A.M., Nagtegaal I.D., Kranenbarg E.K., et al. Pathology Review Committee and the Cooperative Clinical Investigators. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 19 (2001) 1976-1984
76. Frykholm G.J., Pahlman L., and Glimelius B. Combined chemo and radiotherapy vs radiotherapy alone in the treatment of primary non-resectable cancer of the rectum. Int J Radiat Oncol Biol Phys 50 (2001) 433-440
77. Braendengen M., Tveit K.M., Berglund A., et al. A randomised phase III study (LARCS) comparing preoperative radiotherapy alone with chemoradiotherapy in non-resectable rectal cancer. Eur J Cancer Suppl 3 2 (2005) 172 (Abstract 612)
78. Mawdsley S., Glynne-Jones R., Grainger J., et al. Can the histopathological assessment of the circumferential margin following pre-operative pelvic chemo-radiotherapy for T3/4 rectal cancer predict for three year disease free survival?. Int J Radiat Oncol Biol Phys 63 (2005) 745-752
79. Francois Y., Nemoz C.J., Baulieux J., et al. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 Randomised Trial. J Clin Oncol 17 (1999) 2396-2402
80. Glehen O., Chapet O., and Adham M. Long-term results of the Lyon R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer. Br J Surg 90 (2003) 996-998
81. Moore H.G., Gittleman A.E., Minsky B.D., et al. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 47 (2004) 279-286
82. Supiot S., Bennouna J., Rio E., et al. Negative influence of delayed surgery on survival after preoperative radiotherapy in rectal cancer. Colorect Dis 8 (2006) 430-435
83. Dahlberg M., Glimelius B., Graff W., et al. Preoperative radiation affects functional results after surgery for rectal cancer: results from a randomised study. Dis Colon Rectum 41 (1998) 543-549
84. Tepper J.E., O'Connell M., Nieddzwiecki D., et al. Adjuvant therapy in rectal cancer: analysis of stage, sex and local control - final report of Intergroup 0114. J Clin Oncol 20 (2002) 1744-1750
85. Gallagher M.J., Brereton H.D., and Rostock R.A. A prospective study of treatment techniques to minimise the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. Int J Radiat Oncol Biol Phys 12 (1986) 1565-1573
86. Marijnen C.A., van de Velde C.J., Putter H., et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 23 (2005) 1847-1858
87. Pollack J., Holm T., Cedermark B., et al. Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg 93 (2006) 1519-1525
88. Peeters K., van de Velde C., Leer J., et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients - Dutch Colorectal Cancer Group study. J Clin Oncol 23 (2005) 6199-6206
89. Birgisson H., Pahlman L., and Glimelius B. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 23 (2006) 8697-8705
90. Birgisson H., Pahlman L., Gunnarsson U., et al. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 23 (2005) 6126-6131
91. Marijnen C.A.M., Beets-Tan R.G.H., Lahaye M., et al. Local recurrence in the TME trial: can we reduce the radiotherapy field?. Eur J Cancer Suppl 3 2 (2005) 415 (Abstract 1434)
92. Syk E., Torkzad, Blomqvist L., et al. Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer. Br J Surg 93 (2006) 113-119
93. Roels S., Duthoy W., Haustermans K., et al. Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 65 (2006) 1129-1142
94. Krook J.E., Moertel C.G., Gunderson L.L., et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324 (1991) 709-715
95. Gastrointestinal Tumour Study Group. Radiation therapy and fluorouracil with or without somustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 10 (1992) 549-557
96. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264 (1990) 1444-1450
97. Wolmark N., Wieand H.S., Hyams D.M., et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 92 (2000) 388-396
98. O'Connell M.J., Martenson J.A., Wieand H.S., et al. Improving adjuvant therapy of rectal cancer by combining protracted infusional fluorouracil with radiation therapy after curative surgery. N Engl J Med 331 (1994) 502-507
99. Smalley S.R., Benedetti J.K., and Williamson S.K. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 24 (2006) 3542-3547
100. Lee J.H., Lee J.H., Ahn J.H., et al. Randomised trial of post operative adjuvant therapy in stage 2 and 3 rectal cancer to find the optimal sequence of chemotherapy and radiotherapy - a preliminary report. J Clin Oncol 20 (2002) 1751-1758
101. Moertel C.G., Fleming T.R., Macdonald J.S., et al. Levamisole and fluorouracil for adjuvant chemotherapy of resected colon carcinoma. N Engl J Med 322 (1990) 352-358
102. Andre T., Boni C., Mounedji-Boudiaf L., et al. Oxaliplatin, fluorouracil as adjuvant treatment for colon cancer. N Engl J Med 23 (2004) 2343-2351
103. Wolmark H.S., Wieand J.P., Kuebler J.P., et al. A phase III trial comparing FULV to FULV + oxaliplatin in stage II or III carcinoma of the colon: results of NSABP Protocol C-07. J Clin Oncol 23 Suppl (2005) (Abstract 3500)
104. Taal B.G., Van Tinteren H., Zoetmulder F.A., and NACCP group. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br J Cancer 85 (2001) 1437-1443
105. Glimelius B., Dahl O., Cedermark B., et al. Adjuvant chemotherapy in colorectal cancer: a joint analysis by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncol 44 (2005) 904-912
106. Sakumoto J., Ohasi Y., Hamada C., et al. Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomised trials. J Clin Oncol 22 (2004) 484-492